Delivery Order SPE2DX22D0010-SPE2D826FBP76
- Not listed
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg, with a ceiling value of $2,137.71. This competitively awarded, firm fixed-price delivery order was executed on October 23, 2025, with an ultimate completion date of October 24, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules, 25mg, with a ceiling value of $4,993.24. This is a firm fixed price delivery order awarded on November 6, 2025, with an ultimate completion date of November 7, 2025. The contract employs no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 10mg, with a contract ceiling value of $2,071.44 and a completion date of December 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules 25mg, with a ceiling value of $3,780.69. The contract is a firm fixed price delivery order with an ultimate completion date of October 7, 2025, awarded on October 6, 2025. No set-aside designation was applied to this award, indicating it was competitively procured. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 30, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with a ceiling value of $1,055.37 and an ultimate completion date of October 1, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,727.34 delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix (AD) Extended-Release Capsules, 20mg, with an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The order was placed at the contractor's primary location in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 10mg, with a ceiling value of $1,049.57. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion on November 25, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules 25mg with a ceiling value of $4,271.13. The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 24, 2025, and was awarded on July 23, 2025. No set-aside designation was applied to this competitive award. AmerisourceBergen Drug Corp will perform the work at its corporate office...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $4,408.02 delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix (AD) extended-release capsules, 25 mg, with a completion date of September 9, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively on September 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and military healthcare systems....
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules 15mg with a ceiling value of $1,161.92. The contract was awarded on November 14, 2025, with an ultimate completion date of November 17, 2025, and employs firm fixed price terms with no set-aside designation. Performance will take place at the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBP76Delivery Order
The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg, with a ceiling value of $1,540.80. This competitively awarded, non-set-aside contract was executed on December 8, 2025, with an ultimate completion date of December 9, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major pharmaceutical distributor serving federal healthcare needs. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates consistent performance across multiple therapeutic domains, positioning the company as a critical vendor for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/7/25 |